Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Comparison of COVID-19 disease course in hospitalized patients infected by SARS-CoV-2 in first and second waves of the novel coronavirus infection
Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 in first and second waves of the novel coronavirus infection in cohort of Russian adult patients.
Retrospective analysis of medical histories and outcomes in adults with pre-existing conditions after SARS-CoV-2 infection. Comorbidities worsening risk factors measuring through evaluation of range of indicators such as dynamics of diabetes, CKD, COPD, bronchial astma, incidence of hypertonic crises, vascular events and others.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| death | death for any reason | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of cases of Acute Kidney Injury depending on Coexisting Conditions | Number of cases of Acute Kidney Injury depending on Coexisting Conditions | 4 weeks |
| Number of cases of Myocarditis and Acute Coronary Events depending on Coexisting Conditions |
Not provided
Inclusion Criteria:
Suspected or confirmed COVID-19 (according to results of swab-test, antibody test, computed tomography or radiography image)
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Anonymized male and female patients over the age of 18 hospitalised since October, 1st, 2020
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Grigoriy Arutyunov, MD, PhD | Eurasian Association of Therapists | Study Director |
| Ekaterina Tarlovskaya, MD, PhD | Eurasian Association of Therapists | Study Chair |
| Aleksander Arutyunov, MD, PhD | Eurasian Association of Therapists | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Eurasian Association of Therapists | Moscow | 101000 | Russia |
Not provided
| Label | URL |
|---|---|
| design of observational studies "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients" and "Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection" | View source |
| Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors" | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Number of cases of Myocarditis and Acute Coronary Events depending on Coexisting Conditions
| 4 weeks |
| Number of cases of Cytokine Storm depending on Coexisting Conditions | Number of cases of Cytokine Storm depending on Coexisting Conditions | 4 weeks |
| Number of thrombotic and thromboembolic complications of COVID-19 depending on Coexisting Conditions | Number of thrombotic and thromboembolic complications of COVID-19 depending on Coexisting Conditions | 4 weeks |
| Decline in GFR excluding Acute Kidney Injury by the time of discharge depending on Coexisting Conditions | Decline in GFR excluding Acute Kidney Injury by the time of discharge depending on Coexisting Conditions | 4 weeks |
| Rate of cases of health status worsening occured during hospitalisation | Rate of cases of health status worsening occured during hospitalisation | 4 weeks |
| Impact of Kidney Damage on the Course and Prognosis of COVID-19 Infection According to the International Registry "Analysis of Chronic Non-Infectious Diseases Dynamics After Covid-19 Infection in Adult Patients" | View source |
| The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries. | View source |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D003643 | Death |
| D003920 | Diabetes Mellitus |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D008173 | Lung Diseases, Obstructive |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided